SPDR S&P Pharmaceuticals ETF Rating $46.00 -0.50 (-1.08%) Closing price 04:10 PM EasternExtended Trading$46.06 +0.05 (+0.12%) As of 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XPH Aggregate RatingModerate Buy 2.72Holdings in XPH have an aggregate rating of Moderate Buy based on 251 analyst ratings issued in the past year covering 25 companies (78.3% of the portfolio).XPH Aggregate Price Target$46.00High Prediction$46.00Average Prediction$46.00Low Prediction$46.00Holdings in XPH have an aggregate price target of $46.00 and a range of $46.00 to $46.00 covering 25 companies (78.3% of the portfolio).XPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy9 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 XPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.35%TARSTarsus Pharmaceuticals$49.59+0.5%2.5063 of 5 stars2.71$66.67 34.4%74.24%ELANElanco Animal Health$18.63+0.5%2.6289 of 5 stars2.78$17.33 -6.9%9Positive News3.79%AXSMAxsome Therapeutics$116.78-1.4%4.9088 of 5 stars3.13$177.86 52.3%15Positive News3.79%JAZZJazz Pharmaceuticals$125.22-0.7%4.5206 of 5 stars2.88$178.67 42.7%16Positive News3.76%VTRSViatris$9.60-3.6%1.6346 of 5 stars1.80$10.40 8.3%5High Trading Volume3.73%JNJJohnson & Johnson$177.49-0.3%4.6842 of 5 stars2.65$176.29 -0.7%20Positive NewsAnalyst Upgrade3.50%RPRXRoyalty Pharma$35.15-3.3%4.8954 of 5 stars3.33$48.00 36.6%3Positive NewsAnalyst Downgrade3.45%MRKMerck & Co., Inc.$81.07-2.1%4.9965 of 5 stars2.35$107.44 32.5%20Positive News3.36%OGNOrganon & Co.$10.39-2.5%4.5101 of 5 stars2.80$17.33 66.9%5Positive News3.32%CORTCorcept Therapeutics$69.53-4.6%4.7562 of 5 stars3.00$135.25 94.5%53.31%PFEPfizer$23.98+0.5%4.9874 of 5 stars2.39$28.12 17.3%18Positive News3.10%ANIPANI Pharmaceuticals$98.81+1.1%3.9363 of 5 stars3.10$88.25 -10.7%103.10%BMYBristol Myers Squibb$46.34+0.3%4.8617 of 5 stars2.24$56.38 21.7%21Positive News3.08%LLYEli Lilly and Company$748.26-0.9%4.9979 of 5 stars2.68$941.35 25.8%22Trending News2.96%ZTSZoetis$146.34-1.3%4.8568 of 5 stars2.56$200.88 37.3%9Positive News2.81%XERSXeris Biopharma$7.36-1.7%2.649 of 5 stars2.83$7.08 -3.8%6Positive NewsInsider Trade2.76%LQDALiquidia Technologies$26.77+3.0%3.5605 of 5 stars3.00$32.11 20.0%10Positive News2.67%PRGOPerrigo$21.76-2.3%4.9016 of 5 stars2.40$33.00 51.7%5Positive News2.58%SUPNSupernus Pharmaceuticals$43.99-3.2%2.5436 of 5 stars2.50$43.00 -2.3%42.52%PBHPrestige Consumer Healthcare$62.99-0.4%4.5627 of 5 stars2.29$93.33 48.2%7Positive News2.51%HRMYHarmony Biosciences$32.50+0.3%4.5991 of 5 stars3.00$51.00 56.9%10Positive News2.50%PCRXPacira BioSciences$26.86-1.0%3.3116 of 5 stars2.71$30.83 14.8%7Positive News2.43%OCULOcular Therapeutix$12.54-2.1%4.0173 of 5 stars3.00$17.83 42.2%6News CoveragePositive NewsAnalyst ForecastGap Up2.33%LGNDLigand Pharmaceuticals$165.51-0.1%4.2277 of 5 stars3.00$176.50 6.6%6Positive NewsHigh Trading Volume2.31%AMRXAMNEAL PHARMACEUTICALS$9.79-2.1%2.91 of 5 stars3.00$11.60 18.5%5Positive News This page (NYSEARCA:XPH) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XPH Stock Alerts